<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03024749</url>
  </required_header>
  <id_info>
    <org_study_id>D161100003816001</org_study_id>
    <nct_id>NCT03024749</nct_id>
  </id_info>
  <brief_title>Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas</brief_title>
  <acronym>SUIT-SAVM</acronym>
  <official_title>Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas: Multicenter Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hongqi Zhang, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tsinghua Chang Gung Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Hospital of Chinese Armed Police Forces</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Haidian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Rehabilitation Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal arteriovenous fistulas (AVFs) and arteriovenous malformations (AVMs) are complex&#xD;
      neurosurgical lesions that are very challenging to manage. Spinal vascular malformations&#xD;
      account for 3%-4% of all intradural spinal cord mass lesions. Over the last few decades our&#xD;
      understanding of these lesions has dramatically increased thanks to neuroimaging technology&#xD;
      (e.g. spinal angiography and indocyanine green angiography). Various treatment modalities&#xD;
      including conservative observation, endovascular embolization, microsurgical resection,&#xD;
      radiation therapy, and combined therapies have been reported. The treatment for these AVMs&#xD;
      and AVFs depends on their location, the type of malformation, the area of the spine involved,&#xD;
      and the condition of the patient at the time of treatment. Due to the rarity of these spinal&#xD;
      vascular lesions, reports of their management and outcomes have been limited to small series&#xD;
      and case reports. And the rates of obliteration and outcomes are not satisfactory, especially&#xD;
      the spinal AVMs. Spinal vascular lesions are rare but represent a formidable challenge for&#xD;
      the treating neurosurgeon.The purpose of this study is to establish multimodality treatment&#xD;
      mode and evaluate the anatomical cure rate and functional preservation rate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, prospective, observational, registration study. There are nine centers&#xD;
      involved in the study. The investigators set up a more detailed classification system for&#xD;
      spinal vascular malformations. In accordance with inclusion criteria and exclusion criteria,&#xD;
      this cohort study will include 380 samples in the study period of three years. According to&#xD;
      the spinal angiography, the correct diagnosis and treatment strategy will be made. The&#xD;
      minimally invasive surgical treatment methods and new techniques will be adopted such as&#xD;
      spinal superselective angiography, preoperative embolization, intraoperative&#xD;
      electrophysiological monitoring, intraoperative angiography, etc. All the enrolled patients&#xD;
      will be visited a total of four times, postoperative day 1 and postoperative day 7, followed&#xD;
      up postoperative 3 months and 12 months. The anatomical cure rate and spinal cord function&#xD;
      will be assessed objectively. All data will be recorded in the network database platform.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">December 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Change of the spinal cord function</measure>
    <time_frame>1 day before operation and 12 months postoperative</time_frame>
    <description>American Spinal Injury Association(ASIA) Score for evaluating the spinal cord function.Indexes (ASIA score) at baseline (1 day before operation) and 12 months follow-up will be collected, then the change from preoperative to 12 months follow-up will be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anatomic obliteration rate</measure>
    <time_frame>3 months post operation</time_frame>
    <description>the anatomic obliteration rate is determined by angiography 3 months post operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>American Spinal Injury Association(ASIA) Score</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months post operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Aminoff &amp; Logue's Scale (mALS)</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months post operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Denis Pain and Numbness Scale (mDPNS)</measure>
    <time_frame>1 week, 3 months, 6 months, 12 months post operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of perioperative complications</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">380</enrollment>
  <condition>Spinal Cord Vascular Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with spinal AVMs/AVFs&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient diagnosed with spinal vascular diseases including&#xD;
&#xD;
               -  intradural arteriovenous malformation,&#xD;
&#xD;
               -  intradural arteriovenous fistula,&#xD;
&#xD;
               -  dural arteriovenous fistula,&#xD;
&#xD;
               -  extradural arteriovenous malformation,&#xD;
&#xD;
               -  paravertebral arteriovenous malformation,&#xD;
&#xD;
               -  paravertebral arteriovenous fistula,&#xD;
&#xD;
               -  cobbs' syndrome,&#xD;
&#xD;
               -  other spinal arteriovenous metameric syndromes involve the spinal cord.&#xD;
&#xD;
          -  patient not received surgical or interventional treatment before&#xD;
&#xD;
          -  patient with normal cardiac, renal and hepatic function&#xD;
&#xD;
          -  patient capable of understanding the content of the patient information / Informed&#xD;
             Consent Form&#xD;
&#xD;
          -  patient willing and able to participate in the registry&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient received surgical treatment or interventional treatment before&#xD;
&#xD;
          -  patient is pregnant&#xD;
&#xD;
          -  patient allergic to iodine&#xD;
&#xD;
          -  patient unable to complete follow-up&#xD;
&#xD;
          -  patient with cerebral lesions&#xD;
&#xD;
          -  patient with other spinal lesions&#xD;
&#xD;
          -  patient with cardiac, renal or hepatic dysfunction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhang Hongqi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Neurosurgical Department, Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hong Tao, MD</last_name>
    <phone>86-13810000653</phone>
    <email>hongtao.edu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tao Hong</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Tao, MD.</last_name>
      <phone>13810000653</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Lee YJ, Terbrugge KG, Saliou G, Krings T. Clinical features and outcomes of spinal cord arteriovenous malformations: comparison between nidus and fistulous types. Stroke. 2014 Sep;45(9):2606-12. doi: 10.1161/STROKEAHA.114.006087. Epub 2014 Jul 15.</citation>
    <PMID>25028446</PMID>
  </reference>
  <reference>
    <citation>Rangel-Castilla L, Russin JJ, Zaidi HA, Martinez-Del-Campo E, Park MS, Albuquerque FC, McDougall CG, Nakaji P, Spetzler RF. Contemporary management of spinal AVFs and AVMs: lessons learned from 110 cases. Neurosurg Focus. 2014 Sep;37(3):E14. doi: 10.3171/2014.7.FOCUS14236.</citation>
    <PMID>25175433</PMID>
  </reference>
  <reference>
    <citation>Gross BA, Du R. Spinal glomus (type II) arteriovenous malformations: a pooled analysis of hemorrhage risk and results of intervention. Neurosurgery. 2013 Jan;72(1):25-32; discussion 32. doi: 10.1227/NEU.0b013e318276b5d3.</citation>
    <PMID>23096418</PMID>
  </reference>
  <reference>
    <citation>Gross BA, Du R. Spinal pial (type IV) arteriovenous fistulae: a systematic pooled analysis of demographics, hemorrhage risk, and treatment results. Neurosurgery. 2013 Jul;73(1):141-51; discussion 151. doi: 10.1227/01.neu.0000429848.91707.73.</citation>
    <PMID>23615108</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>December 27, 2016</study_first_submitted>
  <study_first_submitted_qc>January 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2017</study_first_posted>
  <last_update_submitted>June 4, 2017</last_update_submitted>
  <last_update_submitted_qc>June 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Xuanwu Hospital, Beijing</investigator_affiliation>
    <investigator_full_name>Hongqi Zhang, MD</investigator_full_name>
    <investigator_title>Director of Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>Spinal Arteriovenous Malformation</keyword>
  <keyword>Spinal Arteriovenous Fistula</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Vascular Diseases</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Arteriovenous Malformations</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

